British Columbia-based Tilray plans to buy Natura Naturals Holdings for up to 70 million Canadian dollars ($52 million) to significantly increase its Canadian cannabis footprint. Natura Naturals - a subsidiary of Natura Naturals Holdings - owns one of Canada’s 126...
Matt Lamers
Matt Lamers's Latest Posts
Cannabis firms in M&A hunt look beyond Canada for growth
Canadian medical cannabis companies are increasingly looking internationally for acquisitions to tap growth while consolidation in the country's marijuana sector continues to steam ahead. Last year, 140 U.S. cannabis companies were targets of mergers and acquisitions,...
US Virgin Islands enacts medical cannabis law, opens tourism avenues
U.S. Virgin Islands Gov. Albert Bryan Jr. has given a new medical marijuana law his stamp of approval, making the territory the latest Caribbean jurisdiction to open its doors to cannabis businesses and potential new tourism opportunities.
CIBC compares cannabis to gold rush, predicts ‘beginning of global seismic shift’
The birth of the legal cannabis industry in Canada is akin to the gold rush, but very few companies will live up to their lofty expectations, according to a new report from one of the country's largest banks. CIBC World Markets, a subsidiary of the Canadian Imperial...
Aurora targets high-margin cannabis market with CA$175M Whistler acquisition
Alberta’s Aurora Cannabis has agreed to acquire privately held British Columbia-based Whistler Medical Marijuana Corp. - one of Canada's first licensed producers - for 175 million Canadian dollars ($131 million) in an all-share transaction. The acquisition will add...
Legal cannabis could skim $55 billion per year from alcohol, tobacco firms
Global alcohol and tobacco companies could face losses of $55 billion a year if a fully legal cannabis industry develops in North America, a new report predicts, a key driver for why those sectors are taking early steps into the blooming marijuana market. “For these...
In Canada, a macro wait for micro licenses in cannabis
Small-scale cannabis growers in Canada are facing such burdensome licensing regulations that fewer than 30 such applications have been made to Health Canada since legalization in October.
CEO of Canadian cannabis giant Aphria out amid short attack, hostile takeover bid
The chief executive officer of one of the biggest cannabis companies in North America plans to depart as the company continues to fend off a short attack and separate hostile takeover. Aphria CEO Vic Neufeld and co-founder Cole Cacciavillani will transition out of...
Canadian marijuana companies raised landmark CA$12 billion in 2018
Marijuana firms in Canada raised a record 11.96 billion Canadian dollars ($9 billion) last year as they prepared to meet demand in the new adult-use market and grow their medical operations globally. That represents a 150% increase over 2017, when Canadian companies...
Chinese delegation will visit Israel to explore medical cannabis opportunities
A Chinese delegation from business and research circles is planning to visit Israel in the coming days to explore opportunities in the medical cannabis sector. Cannabis for medical use remains illegal in China, but if the country’s position...
Canadian marijuana industry targets alcohol, mainstream executives to steer growth
Cannabis corporations in Canada are ramping up their drive to hire executives from the alcohol, tobacco and consumer packaged goods (CPG) sectors to help steer aggressive growth strategies. Personnel in these sectors have experience getting brands on shelves and into...
British Columbia won’t rule out starting own cannabis production scheme ‘in future’
British Columbia says it could consider establishing its own licensing scheme for cannabis production in the future, however the province currently has no plan to take the unprecedented step. "It’s too speculative at this point to comment on what a plan could be,” the...













